Global Live Cell Imaging Market Growth (Status and Outlook) 2024-2030

Global Live Cell Imaging Market Growth (Status and Outlook) 2024-2030

Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes.

The global Live Cell Imaging market size is projected to grow from US$ 1553.3 million in 2023 to US$ 2554.4 million in 2030; it is expected to grow at a CAGR of 7.4% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Live Cell Imaging Industry Forecast” looks at past sales and reviews total world Live Cell Imaging sales in 2023, providing a comprehensive analysis by region and market sector of projected Live Cell Imaging sales for 2024 through 2030. With Live Cell Imaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Cell Imaging industry.

This Insight Report provides a comprehensive analysis of the global Live Cell Imaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Cell Imaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Live Cell Imaging market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Cell Imaging and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Cell Imaging.

The American region holds the major share of the global live cell imaging market, owing to the existing well-established healthcare system, increasing prevalence of cancer cases, and technological advancements.

This report presents a comprehensive overview, market shares, and growth opportunities of Live Cell Imaging market by product type, application, key players and key regions and countries.

Segmentation by type
Equipment
Consumables
Software

Segmentation by application
Hospitals
Pharmaceutical Companies
Biotechnological Companies
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Carl Zeiss (Germany)
Leica Microsystems (Germany)
Olympus (Japan)
GE Healthcare (U.K.)
BD (U.S.)
Thermo Fisher Scientific (U.S.)
Danaher (U.S.)
Sigma-Aldrich (U.S.)
Nikon (Japan)
Molecular Devices (U.S.)
PerkinElmer (U.S.)
BioTek Instruments (U.S.)

Please note: The report will take approximately 2 business days to prepare and deliver.